The DOI matches its Crossref record.
Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods
Abstract
Rationale: Efficacy of mechanical thrombectomy for acute stroke due to large vessel occlusion initiated beyond 6 h of time last seen well has not been demonstrated in randomized trials. Aim: To establish whether subjects considered to have substantial areas of salvageable brain based on age-adjusted clinical core mismatch who can undergo endovascular treatment within 6–24 h from time last seen well (TLSW) have better outcomes at three months compared to subjects treated with standard medical therapy alone. Age-adjusted clinical core mismatch is defined by age (≤80 or >80 years), baseline National Institutes of Health Stroke Scale (NIHSS) (10–20 or ≥21), and core size (0–20 cm 3 in subjects older than 80 and, in subjects younger than 80, 0–30 cm 3 with NIHSS 10–20 and 31–50 cm 3 with NIHSS ≥21). Design: Prospective, randomized, multicenter, Bayesian adaptive-enrichment, open label trial with blinded endpoint assessment. For the purpose of enrolment, ischemic core size will be evaluated by CT perfusion or magnetic resonance imaging-diffusion-weighted imaging measured by automated software (RAPID). Procedures: Subjects with acute ischemic stroke due to computed tomography angiography- or magnetic resonance angiogram-proven arterial occlusion of the intracranial internal carotid and/or proximal middle cerebral artery (M1) with age-adjusted clinical core mismatch in whom treatment can be initiated between 6 and 24 h from TSLW are randomized in a 1:1 ratio to receive mechanical embolectomy with the Trevo device or medical management alone. Sequential interim analyses allowing adaptation of enrolment criteria or stopping new enrolment for futility or predicted success will occur in every 50 randomized patients starting at 150 to a maximum of 500 patients. Study outcomes: The primary endpoint is the modified Rankin Scale score at 90 days. The primary safety outcome is stroke-related mortality at 90 days. Analysis: The primary endpoint, expressed as a utility-weighted modified Rankin Scale score is analyzed using a Bayesian posterior probability with adjustment for ischemic core size. For regulatory reasons, a nested co-primary endpoint analysis was added consisting of the proportion of subjects with modified Rankin Scale 0–2 between the active and control groups also analyzed using a Bayesian model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Yang, P., Song, L., Zhang, Y., Zhang, X., Chen, X., Li, Y., Sun, L., Wan, Y., Billot, L., Li, Q., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01882-7 · Cited by 264
Ko, S.-B., Park, H.-K., Kim, B. M., Heo, J. H., Rha, J.-H., Kwon, S. U., Kim, J. S., Lee, B.-C., Suh, S. H., Jung, C., et al. (2019) · Journal of Stroke · doi:10.5853/jos.2019.00024 · Cited by 63
“Identification of patients with target mismatch in DAWN and DEFUSE 3 DAWN used clinical-core mismatch that was adjusted by age and stroke severity.(16,18) For patients who were ≥80 years and had the NIHSS score ≥10, the ischemic core volume should be less than 21 mL.”
Method
Metadata
- Authors
- Jovin, T. G., Saver, J. L., Ribo, M., Pereira, V., Furlan, A., Bonafe, A., Baxter, B., Gupta, R., Lopes, D., Jansen, O., Smith, W., Gress, D., Hetts, S., Lewis, R. J., Shields, R., Berry, S. M., Graves, T. L., Malisch, T., Rai, A., Sheth, K. N., Liebeskind, D. S., & Nogueira, R. G.
- Venue
- International Journal of Stroke
- Publisher
- SAGE Publications
- Published
- 2017-06-01
- Volume
- 12
- Issue
- 6
- Pages
- 641-652
- ISSN
- 1747-4930 (ISSN-L)
- 1747-4949
- OpenAlex
- W2621274857
- Cited by
- 213
- References
- 0
- FWCI
- 20.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods. https://app.cochat.ai/papers/10.1177/1747493017710341
- The paper
- Jovin, T. G., Saver, J. L., Ribo, M., Pereira, V., Furlan, A., Bonafe, A., Baxter, B., Gupta, R., Lopes, D., Jansen, O., Smith, W., Gress, D., Hetts, S., Lewis, R. J., Shields, R., Berry, S. M., Graves, T. L., Malisch, T., Rai, A., . . . Nogueira, R. G. (2017). Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods. International Journal of Stroke. https://doi.org/10.1177/1747493017710341
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.